US30063P1057 - Common Stock
EXACT SCIENCES CORP
NASDAQ:EXAS (5/17/2024, 7:00:02 PM)
After market: 50.48 +0.1 (+0.2%)50.38
-1.57 (-3.02%)
EXACT Sciences Corp. is a cancer screening and diagnostics company. The company is headquartered in Madison, Wisconsin and currently employs 6,300 full-time employees. The company went IPO on 2001-01-30. The firm provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The firm is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Company’s products include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test and COVID-19 Testing. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
EXACT SCIENCES CORP
5505 Endeavor Lane
Madison WISCONSIN 53719
P: 16082845700
CEO: Kevin T. Conroy
Employees: 6300
Website: https://www.exactsciences.com/
Discover three biotech stocks handpicked by Cathie Wood, offering groundbreaking therapies and substantial growth potential.
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!
EXAS earnings call for the period ending March 31, 2024.
EXAS stock results show that Exact Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
The company reported better-than-expected sales, but losses widened and missed forecasts.
Here you can normally see the latest stock twits on EXAS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: